Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EMPAGLIFLOZIN Cause Balance disorder? 82 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 82 reports of Balance disorder have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 0.2% of all adverse event reports for EMPAGLIFLOZIN.

82
Reports of Balance disorder with EMPAGLIFLOZIN
0.2%
of all EMPAGLIFLOZIN reports
10
Deaths
23
Hospitalizations

How Dangerous Is Balance disorder From EMPAGLIFLOZIN?

Of the 82 reports, 10 (12.2%) resulted in death, 23 (28.0%) required hospitalization, and 4 (4.9%) were considered life-threatening.

Is Balance disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN. However, 82 reports have been filed with the FAERS database.

What Other Side Effects Does EMPAGLIFLOZIN Cause?

Diabetic ketoacidosis (3,644) Fungal infection (1,941) Blood glucose increased (1,797) Euglycaemic diabetic ketoacidosis (1,769) Weight decreased (1,661) Urinary tract infection (1,439) Ketoacidosis (1,411) Dizziness (1,372) Nausea (1,333) Vomiting (1,201)

What Other Drugs Cause Balance disorder?

DALFAMPRIDINE (3,753) DIMETHYL (2,143) FINGOLIMOD (1,860) TERIFLUNOMIDE (1,565) INTERFERON BETA-1A (1,454) LENALIDOMIDE (1,395) ADALIMUMAB (1,296) PREGABALIN (1,277) NATALIZUMAB (1,275) CARBIDOPA\LEVODOPA (1,271)

Which EMPAGLIFLOZIN Alternatives Have Lower Balance disorder Risk?

EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN EMPAGLIFLOZIN vs EMSAM EMPAGLIFLOZIN vs EMTRICITABINE

Related Pages

EMPAGLIFLOZIN Full Profile All Balance disorder Reports All Drugs Causing Balance disorder EMPAGLIFLOZIN Demographics